Money Is Moving

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Public market insider buying at Cybin (E:CYBN)

Updated Wednesday Nov 24, 2021 02:04 AM EDT

Aaron Frank Bartlone, a Subsidiary Executive, acquired 59,999 Common Shares on a direct ownership basis at a price of $1.620USD on November 22nd, 2021. This represents a $123,248 investment into the company's shares and an account share holdings change of 9.4%.

Cybin is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Cybin Inc. is a Canada-based biopharmaceutical company. The Company is focused on progressing psychedelic therapeutics. The Company operates business through its subsidiary Cybin Corp. The Company operates through two segments: Serenity Life Sciences Inc. (Serenity Life) and Cybin US Holdings Inc. (Cybin U.S.) that focus on the research and development of psychedelic pharmaceutical products, and Natures Journey Inc. that focuses on consumer mental wellness, including non-psychedelic nutraceutical products. The Company focuses on the development of treatment regimens consisting of psychedelic molecules and related clinical protocols. Its subsidiaries include Natures Journey Inc. (Journey), Serenity Life Sciences Inc. (Serenity), Cybin US Holdings Inc. (Cybin US), Adelia Therapeutics Inc. (Adelia) and Cybin IRL Limited.

INK Edge Outlook

CONDITIONS:
Latest
6 months ago
1 year ago
Overall
Mixed
Mixed
N/A
The INK Edge Outlook is a quantitative process that ranks a stock based on our V.I.P. criteria.
View outlooks on all Canadian listed stocks at inkresearch.com.
Two-week free trial for first time users.
Go to Cybin Inc. (CYBN)'s company page

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Comment On!

No Comments

Twitter

Search (past week) for $CYBN.CA

  • No tweets found

Stocktwits